Use of chronic medications among a large, commercially-insured US population

被引:13
|
作者
Roe, CM
McNamara, AM
Motheral, BR
机构
[1] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[2] Express Scripts Inc, Womens Hlth, Maryland Hts, MO 63043 USA
[3] Express Scripts Inc, Outcomes Res, Maryland Hts, MO USA
关键词
chronic medication use; gender differences; sex differences; pharmacy claim database;
D O I
10.1002/pds.700
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To examine use of chronic therapies by females and males of all ages. Methods Participants were 1295 948 members of a large US pharmacy benefit manager. The use of chronic medications by males and females during 1999 was examined overall and within 16 commonly-used chronic drug groups. Dependent variables were use of a drug group, number of drug groups used, number of prescriptions filled and sum of costs, both within each drug group and overall, Combination therapy was defined as using at least two of the 16 chronic therapy groups during 1999. Results Females were more likely than males to use chronic medications during the study year (36.5 vs. 22.4%, p < 0.001). Generally, the likelihood of using a chronic medication increased with age for both sexes. Commonly-used chronic medications accounted for 54 and 50% of prescriptions for females and males respectively, and for 53% of total drug costs for both sexes. There were few meaningful sex differences in the likelihood of using particular drug groups. Of those who took chronic drugs 14% used combination chronic therapy. Conclusions This study provides demographic information regarding treatment of chronic conditions that can be used to aid policy decisions and to provide an impetus for future research. Copyright (C) 2002 John Wiley & Sons, Ltd.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 50 条
  • [41] Predictors ofHealth Plan Disenrollment Among Commercially-Insured Adults in the United States
    Butler, Anne M.
    Todd, Jonathan V.
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 354 - 355
  • [42] COMPARATIVE INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN DIFFERENT AGE GROUPS: A COMMERCIALLY-INSURED, POPULATION-BASED US STUDY
    Keyashian, Kian
    Dehghan, Melody
    Sceats, Lindsay A.
    Kin, Cindy
    Limketkai, Berkeley
    Park, K. T.
    GASTROENTEROLOGY, 2019, 156 (03) : S64 - S64
  • [43] Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
    Dai, Dingwei
    Sharma, Ajay
    Phillips, Amy L.
    Lobo, Carroline
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 125 - 133
  • [44] Healthcare Costs of Cushing's Disease from the US Commercially-Insured Perspective.
    Swearingen, B.
    Boulanger, L.
    Wu, N.
    Chen, S.
    Pulgar, S.
    Biller, B. M. K.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [45] Treatment patterns and clinical outcomes among patients with biliary tract cancers in a large commercially insured US population
    Valderrama, Adriana
    Singhal, Mukul
    Wang, Liya
    Nepal, Bal
    Kamble, Shital
    Grabner, Michael
    Malhotra, Usha
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [46] Prevalence and impact of antipsychotic discontinuation among commercially-insured patients with bipolar disorder
    Khandker, Rezaul
    Chekani, Farid
    Limone, Brendan
    Riehle, Ellen
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 878 - 885
  • [47] The Burden of Hepatorenal Syndrome among Commercially-Insured and Medicare Patients in the United States
    Rice, J. B.
    White, Alan
    Galebach, Philip J.
    Korenblat, Kevin M.
    Wagh, Aneesha
    Lovelace, Belinda
    Wan, George J.
    Jamil, Khurram
    HEPATOLOGY, 2016, 64 : 1033A - 1034A
  • [48] Trends in Ambulatory and Home Blood Pressure Monitoring Use for Confirmation of Hypertension or Resistant Hypertension Among the Commercially-Insured in the US, 2008-2017
    Smith, Steven M.
    Desai, Raj
    Dietrich, Eric
    Park, Haesuk
    HYPERTENSION, 2019, 74
  • [49] COMPARATIVE INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN DIFFERENT AGE GROUPS: A COMMERCIALLY-INSURED, POPULATION-BASED US STUDY
    Keyashian, Kian
    Dehghan, Melody
    Sceats, Lindsay A.
    Kin, Cindy
    Limketkai, Berkeley
    Park, K. T.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S44 - S44
  • [50] DIFFUSION OF TELEMEDICINE IN A LARGE COMMERCIALLY INSURED POPULATION
    Barnett, Michael L.
    Ray, Kristin N.
    Souza, Jeffrey
    Mehrotra, Ateev
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S163 - S163